🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

LifeVantage Corporation LFVN R2K

Consumer Defensive · Packaged Foods · United States
https://www.lifevantage.com
Company Profile ↓
$5.86
-58.53% 1Y
Mkt Cap$73.41M
P/E14.65
P/B2.37
Div. Yield3.17%
52W High$14.13
52W Low$3.96
Book Value$2.68
EPS (TTM)$0.40

Company Overview

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 27.3%.

Steady Revenue Expansion

Revenue has grown at a 13.5% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 14.7, below the sector median of 19.6.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.29.

Dividend Income

Offers a dividend yield of 3.17%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Jun 2025 Revenue of $228.53M (+14.2% YoY); net profit $9.80M.
  • Trailing 12 Months Year-on-year growth — revenue -23.1%, earnings -32.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 13.5%, profit CAGR -3.2%.

Growth & Price Performance

Compounded Sales Growth

5 Years:13.48%
1 Year:-23.10%

Compounded Profit Growth

5 Years:-3.22%
1 Year:-32.80%

Stock Price Performance

1 Year:-58.53%
6 Months:+17.02%
3 Months:-7.27%
1 Month:-6.84%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 19% of range
$3.96 $14.13
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)37.40 · Neutral
Price Performance
1M-6.84%
3M-7.27%
6M+17.02%
1Y-58.53%
Valuation vs Sector

P/E of 14.65 is below the sector median of 19.62 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Healthy ROCE of 27.3%.
  • Compounding revenue at 13.5% over 5 years.
  • Attractive dividend yield of 3.17%.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Earnings shrank at -3.2% CAGR over 5 years.
  • Trading 58.5% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
14.65
Industry PE
19.62
Forward P/E
15.16
PEG Ratio
0.36
Book Value
$2.68
Price to Book
2.37
P/S
0.44
EV/EBITDA
7.85
Dividend Yield
3.17%

Growth (CAGR)

Revenue 5Y
13.48%
Profit 5Y
-3.22%
Revenue (YoY)
-23.10%
Earnings (YoY)
-32.80%

Profitability & Returns

ROCE
27.27%
ROE
14.87%
ROA
6.25%
Profit Margin
2.78%
Op Margin
3.93%
Gross Margin
77.56%
EPS (Latest Qtr)
$0.11
EPS (TTM)
$0.40

Balance Sheet & Liquidity

Debt/Equity
0.29
Quick Ratio
0.95
Current Ratio
1.89
Debt
$9.87M
Total Assets
$62.13M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
11.99%
Chg in Prom Hold
-0.56%
FII / Inst Holding
53.60%
Chg in FII Hold
-0.07%

Financial Snapshot

Enterprise Value
$73.41M
Total Revenue (TTM)
$182.59M
EBITDA
$9.47M
Free Cash Flow
$6.00M
Operating Cash Flow
$10.24M
Shares Outstanding
12.53M
Gross Margin
77.56%
Payout Ratio
46.25%

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 LFVN LifeVantage Corporation R2K 5.86 14.65 $73.41M 3.17% 27.27% 14.87% 13.48% -3.22%
2 WMT Walmart Inc. SPXR3K 119.89 43.44 $951.18B 0.93% 16.83% 22.31% 3.82% 3.24%
3 COST Costco Wholesale Corporation NDXSPXR3K 1,003.32 48.38 $444.60B 0.62% 25.96% 28.40% 8.16% 11.45%
4 KO The Coca-Cola Company SPXR3K 92.71 27.84 $398.89B 2.41% 16.47% 42.05% 2.86% 4.46%
5 PG The Procter & Gamble Company SPXR3K 161.02 24.32 $374.28B 2.95% 22.49% 30.29% 0.52% 1.59%
6 PM Philip Morris International Inc. SPXR3K 199.47 27.40 $310.90B 3.09% 34.03% -113.55% -1.69% 3.57%
7 PEP PepsiCo, Inc. NDXSPXR3K 135.77 17.79 $185.46B 4.43% 15.41% 51.51% 4.93% 2.11%
8 BUD Anheuser-Busch InBev SA/NV 84.26 18.16 $147.21B 1.80% 8.49% 11.39% 0.88% 4.63%
9 MO Altria Group, Inc. SPXR3K 74.31 15.64 $124.08B 6.37% 38.27% - 1.24% -1.89%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024Sep 2024Dec 2024Mar 2025Sep 2025Dec 2025Mar 2026
Revenue --------49.13M49.48M50.56M54.03M55.61M58.17M56.01M56.17M56.23M61.24M56.08M59.37M54.83M59.01M51.57M54.78M53.22M52.19M50.00M50.94M51.77M53.66M53.74M51.36M51.62M48.24M47.21M67.76M58.44M47.56M48.93M43.72M
Gross Profit 38.38M44.15M46.45M43.63M46.06M41.45M36.77M41.75M40.39M40.37M41.64M45.96M46.41M48.37M46.74M46.46M47.04M51.01M46.98M49.92M45.43M48.82M42.75M44.99M43.79M42.51M40.35M41.61M41.83M41.90M43.12M41.18M40.56M38.07M37.72M54.57M47.33M37.82M36.21M34.54M
Operating Income 2.67M3.03M3.63M-1.99M700.00K223.00K-1.40M2.33M2.30M-1.32M581.00K2.24M-2.58M3.65M3.03M-3.50M5.45M2.09M-4.61M-358.00K1.82M-1.29M-1.23M1.60M749.00K-1.26M1.93M2.57M3.43M4.05M2.27M487.00K1.68M
Net Income 1.07M1.60M1.00M2.44M1.18M283.00K61.00K84.00K817.00K317.00K1.64M2.99M911.00K829.00K1.78M3.91M1.76M4.30M1.66M3.82M2.45M3.81M1.72M4.91M3.32M79.00K1.14M-1.42M610.00K-1.06M1.02M629.00K-656.00K1.66M1.83M2.55M3.47M2.15M276.00K1.36M
Diluted EPS 0.080.110.070.170.080.020.000.010.060.020.120.210.060.060.120.260.120.300.110.260.170.260.120.350.250.010.09-0.110.05-0.080.080.05-0.050.130.140.190.260.170.020.11
R&D Expense 200.00K---300.00K300.00K200.00K-300.00K300.00K300.00K-400.00K500.00K100.00K-200.00K300.00K200.00K-200.00K200.00K200.00K-200.00K200.00K100.00K-100.00K200.00K200.00K200.00K100.00K200.00K300.00K200.00K400.00K300.00K200.00K200.00K

Profit & Loss (Annual)

Figures in USD.

Metric Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Revenue 38.92M126.18M208.18M213.97M190.34M206.54M199.49M203.20M225.96M232.91M220.18M206.36M213.40M200.16M228.53M
Gross Profit 33.00M108.13M171.53M180.77M162.33M172.61M166.03M168.36M187.99M194.95M181.99M168.26M170.01M158.72M183.67M
Operating Income 3.70M21.46M12.07M19.45M13.90M13.41M4.45M10.32M9.81M15.47M17.61M7.58M4.26M4.33M12.20M
Net Income -50.79M12.47M7.61M11.38M7.12M6.11M1.61M5.76M7.43M11.55M12.89M3.12M2.54M2.94M9.80M
Diluted EPS -0.690.110.060.710.500.420.110.410.500.790.900.240.200.230.75
R&D Expense 509.00K1.40M2.90M2.00M2.40M1.00M1.10M1.20M1.10M900.00K700.00K700.00K600.00K700.00K1.40M

Balance Sheet (Annual)

Figures in USD.

Metric Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jul 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Assets -12.50M44.53M55.48M54.00M39.78M50.85M45.25M51.14M-55.27M58.88M78.73M70.71M66.12M60.30M71.96M
Total Equity -16.18M-20.81M28.28M33.95M2.33M1.81M10.65M14.53M21.95M21.94M27.20M33.25M36.81M31.52M34.65M25.99M34.64M
Cash & Equivalents 1.64M6.37M24.65M26.30M20.39M13.90M7.88M11.46M16.65M-18.82M22.14M23.17M20.19M21.61M16.89M20.20M
Long Term Debt ---025.07M8.53M7.41M5.44M3.41M-0------
Total Liabilities -33.31M16.25M21.54M50.01M36.46M40.21M30.72M29.20M-28.07M25.62M41.92M39.19M31.47M34.31M37.32M
Current Liabilities -13.38M16.03M20.57M22.70M25.86M30.63M23.36M23.80M-26.20M25.02M25.20M25.73M19.61M22.31M27.22M

Cash Flows (Annual)

Figures in USD.

Metric Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Operating Cash Flow 4.68M19.39M10.66M12.11M13.22M6.04M6.60M13.26M17.79M18.33M16.27M7.96M6.83M12.20M11.88M
Investing Cash Flow -89.00K-1.90M-5.08M-2.25M-1.16M-562.00K-1.05M-4.65M-4.51M-2.68M-3.73M-1.53M-3.06M-2.25M-1.37M
Financing Cash Flow 169.00K746.00K-4.02M-15.80M-18.45M-11.70M-1.96M-3.50M-11.12M-12.42M-11.45M-8.95M-2.36M-14.42M-7.60M
Capital Expenditure -122.00K-2.19M-5.08M-1.90M-1.16M-562.00K-1.05M-4.65M-2.51M-2.68M-3.74M-1.53M-3.07M-2.25M-1.37M
Free Cash Flow 4.56M17.20M5.58M10.21M12.06M5.47M5.54M8.61M15.28M15.64M12.53M6.43M3.76M9.95M10.51M
Share Buybacks 0976.00K7.12M46.17M9.85M001.50M4.66M5.41M11.93M8.83M822.00K6.43M3.15M
Dividends Paid ---------00378.00K1.59M6.94M2.07M

Ratios (Annual)

Figures in %.

Metric Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Gross Margin % 84.8%85.7%82.4%84.5%85.3%83.6%83.2%82.9%83.2%83.7%82.7%81.5%79.7%79.3%80.4%
Operating Margin % 9.5%17.0%5.8%9.1%7.3%6.5%2.2%5.1%4.3%6.6%8.0%3.7%2.0%2.2%5.3%
Net Margin % -130.5%9.9%3.7%5.3%3.7%3.0%0.8%2.8%3.3%5.0%5.9%1.5%1.2%1.5%4.3%
ROE % 244.1%44.1%22.4%487.9%394.5%57.3%11.1%26.2%27.3%34.7%35.0%9.9%7.3%11.3%28.3%
ROCE % -419.8%75.3%34.6%62.1%99.8%66.3%20.3%37.8%33.8%45.7%32.9%16.8%9.2%11.4%27.3%

Shareholding Pattern

Insiders
11.99%
Institutions
53.60%
Public Float
60.91%

Top Institutional Holders

#Holder% HeldSharesValue
1 Capital Management Corporation 14.92% 1.88M $11.27M
2 Renaissance Technologies, LLC 5.32% 669.42K $4.02M
3 Vanguard Capital Management LLC 3.41% 429.20K $2.58M
4 Blackrock Inc. 2.13% 268.61K $1.61M
5 Dimensional Fund Advisors LP 2.04% 256.30K $1.54M
6 Envestnet Asset Management Inc. 1.83% 229.91K $1.38M
7 Susquehanna International Group, LLP 1.34% 169.05K $1.01M
8 American Century Companies Inc 1.15% 144.39K $866.32K
9 Jane Street Group, LLC 1.10% 138.06K $828.34K
10 Geode Capital Management, LLC 0.96% 120.83K $724.98K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for LFVN

Google News ue, 28 Apr 2026

Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPM1VSRFVaamY4OWhoRG1IdzZYXzRnMllLN2xNUmx4aFhQYm9zNVRDWWp5Z2dDbk5WLWE5WHhxNVk1VXZOTXFGbzgwS0FiYVBaQVFPZnZlcTFkZmZtQnpzaTd2SkVORjdVeWRObFFUelVpUjNYYlM4Z3psdG1ycXpCVmxIdU1WVFNfWWxtaD…

Google News hu, 25 Dec 2025

LFVN Stock Price and Chart — NASDAQ:LFVN - TradingView

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBhZXdnNWdrQ3R2WFNsSjZPWVpBV05fNFFobGc5MHEtdmdGcFdBazluVGlUano2N0cwVS1OOVdzdEhUdUxzOUR6MW5DcVVWT05FVXBwUmtOclEwUWxH?oc=5" target="_blank">LFVN Stock Price and Chart — NASDAQ:LFVN</a…

Google News Wed, 03 Jun 2026

Small-cap food and personal care names see aggressive short positioning: VITL, BYND, LFVN (VITL:NASDAQ) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZnFkMkRUUTQ4MGZ2RHlTMkJXTTdpdzI5TzgwY05tdXFfa0x1dUR1S1ZfdkFlUng3MTRJN2lrdWhpUnFnOUVmYkw2Y0NlOTdYU3B6RjNGeHZ3TFE1WVhJNW9aV2t4S2RfYTEyMUl0WjFSWDRNczlXUXUxcXlLSXJnTTV4LTJTQVltX1pDck…

Google News Fri, 09 Oct 2026

Lifevantage (LFVN) CFO receives 53,623 performance shares, subject to financial targets and continued service. - Stock Titan

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQQl9JM1A1UlFkaFVYYnRqYUtuYUdFb2dQelgyU1VNNnY2VDZKcUhXdHB3ajVoVUJFYlFCa3lKWDlQaHpTZVJxYlZ6bWoxd1pxM2NpWFVqcXI2ckJBbmQzVXUzQmN5bmd5UlBfRVBuM0VwVThaUng1dEVIcHhuMWtHOWpVdkUtaW9rTFhzdF…

Google News hu, 04 Jun 2026

$LFVN stock is up 19% today. Here's what we see in our data. - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOdnBERmtqdjJVNzlzOURuZDloYU9zczFCS21Qd2t1ZUIwSkowaUh0bE1GLUVHckJocGRKMHIxR3NUNU5KYk5pZFhJNUhQZ1VESzZCZVNtMTdtOUpSUW9PMWhrbElHR1Q4QU1qZFk2cFpOZ0VkRXpaa3cyZzB2Sk5uQWNLUEMwN1pDZ2JlSD…

Google News Sat, 09 Mar 2024

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBIRXZycVF5OHpFbFI2angzS2doZVRRTDZmVDVETTlqWDNxN0lzZDNBRVNRVjNfTGpaN3JoOXoyd1ZCNmlMMk43ZnRuRjAzSktO?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>&nbsp;&nbsp;<fon…

LFVN — Frequently Asked Questions

What is the current share price of LifeVantage Corporation (LFVN)?

As of 2026-10-23 16:27 PDT, LifeVantage Corporation (LFVN) trades at $5.86 on NasdaqCM. Its 52-week range is $3.96 to $14.13.

What is the market capitalisation of LFVN?

LifeVantage Corporation (LFVN) has a market capitalisation of $73.41M on NasdaqCM.

What is the P/E ratio of LFVN?

LFVN trades at a trailing price-to-earnings (P/E) ratio of 14.65. The industry average P/E is 19.62. Its price-to-book (P/B) ratio is 2.37.

Does LFVN pay a dividend?

LifeVantage Corporation (LFVN) currently offers a dividend yield of 3.17%.

What is the return on equity (ROE) of LFVN?

LFVN has a return on equity (ROE) of 14.87%. Its return on capital employed (ROCE) is 27.27%.

Is LFVN a good stock to buy?

This page provides a data-driven analysis of LifeVantage Corporation (LFVN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space